A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy

被引：0
作者：
Panagis Galiatsatos
Cheri Wilson
Jaime O’Brien
Anna J. Gong
Dylan Angiolillo
James Johnson
Carlie Myers
Sara Strout
Stephen Mathai
Gina Robinson
Nicholas R. Rowan
Clifford R. Weiss
机构：
[1] Johns Hopkins School of Medicine,Division of Pulmonary and Critical Care Medicine
[2] The Center of Clinical Excellence for Hereditary Hemorrhagic Telangiectasias at the Johns Hopkins Hospital,Medicine for the Greater Good
[3] Office of Diversity,Division of Anesthesiology and Critical Care Medicine
[4] Inclusion,Albert Gnaegi Center for Health Care Ethics
[5] and Health Equity,Department of Pharmacy
[6] Johns Hopkins School of Medicine,undefined
[7] Johns Hopkins School of Medicine,undefined
[8] Saint Louis University,undefined
[9] Johns Hopkins Hospital,undefined
来源：
Orphanet Journal of Rare Diseases | / 17卷
关键词：
Hereditary hemorrhagic telangiectasia; Bevacizumab; Race; Health equity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 110 条
  • [1] Dakeishi M(2002)Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan Hum Mutat 19 140-148
  • [2] Shioya T(2020)Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia Ann Intern Med 173 989-1001
  • [3] Wada Y(2018)Clinical features and treatment of hereditary hemorrhagic telangiectasia Medicine (Baltimore) 97 33-e1916
  • [4] Faughnan ME(2012)A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study Orphanet J Rare Dis 7 e1909-289
  • [5] Mager JJ(2021)Casting a health equity lens on endocrinology and diabetes J Clin Endocrinol Metab 106 273-245
  • [6] Hetts SW(2017)Disparities in liver cancer occurrence in the United States by race/ethnicity and state CA Cancer J Clin 67 238-95
  • [7] Li S(2015)Disparities in cardiovascular disease risk in the United States Curr Cardiol Rev 11 16-166
  • [8] Wang SJ(2007)Utilization of the PICO framework to improve searching PubMed for clinical questions BMC Med Inform Decis Mak 7 91-314
  • [9] Zhao YQ(2014)Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia Allergy Rhinol (Providence) 5 155-231
  • [10] Pierucci P(2018)Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding Mayo Clin Proc 93 E313-2989
12345678910